Financhill
Back

Applied Therapeutics, Inc. 10K Form

Sell
15

APLT
Applied Therapeutics, Inc.

Last Price:
$0.22
Seasonality Move:
28.77%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive APLT News And Ratings

See the #1 stock for the next 7 days that we like better than APLT

APLT Financial Statistics

Sales & Book Value

Annual Sales: $455K
Cash Flow: $-18.4M
Price / Cash Flow: 0
Annual Sales: $0.00
Price / Book: 1.8

Profitability

EPS (TTM): -0.10000
Net Income (TTM): $-18.1M
Gross Margin: $30K
Return on Equity: -77.88%
Return on Assets: -28.18%

Applied Therapeutics, Inc. Earnings Forecast

Key Applied Therapeutics, Inc. Financial Ratios

  • The Gross Profit Margin over the past 4 years for APLT is 6.59%.
  • The Selling, General & Administrative Expenses for APLT have been equal to 12,309.89% of Gross Profit Margin.
  • The Research & Development expenses have been 10,712.97% of Revenue.
  • The Net Earning history of APLT is -23,214.07% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 4 years.

Applied Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: APLT
CUSIP: 03828A
Website: appliedtherapeutics.com

Debt

Debt-to-Equity Ratio: -4.46
Current Ratio: 0.96
Quick Ratio: 0.36

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

APLT Technical Analysis vs Fundamental Analysis

Sell
15
Applied Therapeutics, Inc. (APLT) is a Sell

Is Applied Therapeutics, Inc. a Buy or a Sell?